Spondyloarthritis: Update on pathogenesis and management

American Journal of Medicine

Volumn 118, Issue 6, 2005, Pages 592-603

  Reveille, John D ^a   Arnett, Frank C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Ankylosing spondylitis; Genetics; Pathophysiology; Spondyloarthritis; Treatment

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AUTOANTIGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CIPROFLOXACIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; HLA B27 ANTIGEN; INDOMETACIN; INFLIXIMAB; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE; THALIDOMIDE; TOLMETIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL CRAMP; ANAPHYLAXIS; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; BIOACCUMULATION; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHROMOSOME ANALYSIS; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEVER; FLUSHING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENOME ANALYSIS; HIP OSTEOARTHRITIS; HUMAN; INTESTINE; INTRACELLULAR KILLING; KLEBSIELLA PNEUMONIAE; NAUSEA; NEUROPATHY; OSTEOPOROSIS; OSTEOTOMY; PATHOGENESIS; PATIENT EDUCATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; REACTIVE ARTHRITIS; REVIEW; SALMONELLA; SEDATION; SHIGELLA; SIDE EFFECT; SPINE FRACTURE; SPINE MALFORMATION; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; YERSINIA;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DISEASE SUSCEPTIBILITY; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19544368444     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.01.001     Document Type: Review

References (116)

1. F.C. Arnett Seronegative spondyloarthropathies D.C. Dale D.D. Federman ACP Medicine, 2004-2005 2004 Web MD New York 1350 1361
2. S.J. van der Linden, D. van der Heijde Spondylarthopathies ankylosing spondylitis S. Ruddy E.D. Harris C.B. Sledge Kelley's Textbook of Rheumatology 6th ed. 2000 WB Saunders Philadelphia 1039 1053
3. T.M. Martin, J.R. Smith, J.T. Rosenbaum Anterior uveitis current concepts of pathogenesis and interactions with spondyloarthopathies Curr Opin Rheumatol. 14 2002 337 341
4. L. Bergfeldt HLA-B27-associated cardiac disease Ann Intern Med. 127 1997 621 629
5. M.A. Brown, S.H. Laval, S. Brophy, A. Calin Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis Ann Rheum Dis. 59 2000 883 886
6. M.A. Brown, L.G. Kennedy, A.J. MacGregor Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment Arthritis Rheum. 40 1997 1823 1828
7. R.L. Allen, T. Raine, A. Haude Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures J Immunol. 167 2001 5543 5547
8. M.A. Brown, B.P. Wordsworth, J.D. Reveille Genetics of ankylosing spondylitis Clin Exp Rheumatol. 20 6 Suppl 28 2002 S43 S49
9. P. Ekman, J. Kirveskari, K. Granfors Modification of disease outcome in Salmonella-infected patients by HLA-B27 Arthritis Rheum. 43 2000 1527 1534
10. J.D. Reveille, E.J. Ball, M.A. Khan HLA-B27 and genetic predisposing factors in spondyloarthropathies Curr Opin Rheumatol. 13 2001 265 272
11. G.M. Mody, F.A. Parke, J.D. Reveille Articular manifestations of human immunodeficiency virus infection Best Pract Res Clin Rheumatol. 17 2003 265 287
12. V. Montserrat, M. Marti, J.A. Lopez de Castro Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis J Immunol. 170 2003 5778 5785
13. R.C. Hillig, M. Hulsmeyer, W. Saenger Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association J Biol Chem. 279 2004 652 653
14. M. Hulsmeyer, M.T. Fiorillo, F. Bettosini Dual, HLA-B27 subtype-dependent conformation of a self-peptide J Exp Med. 199 2004 271 281
15. N.S. Dangoria, M.L. DeLay, D.J. Kingsbury HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum J Biol Chem. 277 2002 23459 23468
16. L.A. Bird, C.A. Peh, S. Kollnberger Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling Eur J Immunol. 33 2003 748 759
17. S. Kollnberger, L. Bird, M.Y. Sun Cell-surface expression and immune receptor recognition of HLA-B27 homodimers Arthritis Rheum. 46 2002 2972 2982
18. W. Kuon, H.G. Holzhutter, H. Appel Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases J Immunol. 167 2001 4738 4746
19. M.T. Fiorillo, M. Maragno, R. Butler CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis J Clin Invest. 106 2000 47 53
20. N. Dulphy, M.A. Peyrat, V. Tieng Common intra-articular T cell expansions in patients with reactive arthritis identical beta-chain junctional sequences and cytotoxicity toward HLA-B27 J Immunol. 162 1999 3830 3839
21. P. Ekman, M. Saarinen, Q. He HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines Infect Immun. 70 2002 1609 1614
22. R.D. Inman, U. Payne Determinants of synoviocyte clearance of arthritogenic bacteria J Rheumatol. 30 2003 1291 1297
23. L.H. Boyle, J.C. Goodall, S.S. Opat, J.S. Gaston The recognition of HLA-B27 by human CD4(+) T lymphocytes J Immunol. 167 2001 2619 2624
24. S.M. van der Linden, H.A. Valkenburg, B.M. de Jongh, A. Cats The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population Arthritis Rheum. 27 1984 241 249
25. M.A. Brown, L.G. Kennedy, C. Darke The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis Arthritis Rheum. 41 1998 460 465
26. R. Said-Nahal, C. Miceli-Richard, C. Gautreau The role of HLA genes in familial spondyloarthropathy a comprehensive study of 70 multiplex families Ann Rheum Dis. 61 2002 201 206
27. D.P. Singal, J. Li, G. Zhang Microsatellite polymorphism of the MICA gene and susceptibility to rheumatoid arthritis Clin Exp Rheumatol. 19 2001 451 452
28. S. Gonzalez, J.C. Torre-Alonso, J. Martinez-Borra TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients J Rheumatol. 28 2001 1288 1293
29. T. Hohler, T. Schaper, P.M. Schneider Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals Arthritis Rheum. 41 1998 1489 1492
30. G. Vargas-Alarcon, J.D. Londono, G. Hernandez-Pacheco Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies Ann Rheum Dis. 61 2002 48 51
31. A. Fraile, M.D. Collado, L. Mataran TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis Exp Clin Immunogene. 17 2000 199 204
32. W.P. Maksymowych, S. Tao, J. Vaile LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis J Rheumatol. 27 2000 183 189
33. C. Murray, D.L. Mann, L.N. Gerber Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex J Clin Invest. 66 1980 670 675
34. T.R. Orchard, S. Thiyagaraja, K.I. Welsh Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease Gastroenterology. 118 2000 274 278
35. S.H. Laval, A. Timms, S. Edwards Whole-genome screening in ankylosing spondylitis evidence of non-MHC genetic-susceptibility loci Am J Hum Genet. 68 2001 918 926
36. S.M. Monowarul Islam, J. Numaga, Y. Fujino HLA-DR8 and acute anterior uveitis in ankylosing spondylitis Arthritis Rheum. 38 1995 547 550
37. G. Zhang, J. Luo, J. Bruckel Genetic studies in familial ankylosing spondylitis susceptibility Arthritis Rheum. 50 2004 2246 2254
38. C. Miceli-Richard, H. Zouali, R. Said-Nahal Significant linkage to spondyloarthropathy on 9q31-34 Hum Mol Genet. 13 2004 1641 1648
39. R.P. Nair, P. Stuart, T. Henseler Localization of psoriasis- susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C Am J Hum Genet. 66 2000 1833 1844
40. J. Tomfohrde, A. Silverman, R. Barnes Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q Science. 264 1994 1141 1145
41. K.G. Becker, R.M. Simon, J.E. Bailey-Wilson Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases Proc Natl Acad Sci (USA). 95 1998 9979 9984
42. P. Rahman, S. Bartlett, F. Siannis CARD15 a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis Am J Hum Genet. 73 2003 677 681
43. J.-P. Hugot, P. Laurent-Puig, C. Gower-Rousseau Mapping of a susceptibility locus for Crohn's disease on chromosome 16 Nature (London). 379 1996 821 823
44. D.K. Bonen, J.H. Cho The genetics of inflammatory bowel disease Gastroenterology. 124 2003 521 536
45. A.M. Crane, L. Bradbury, D.A. van Heel Role of NOD2 variants in spondylarthritis Arthritis Rheum. 46 2002 1629 1633
46. C. Miceli-Richard, H. Zouali CARD15/NOD2 analyses in spondylarthropathy Arthritis Rheum. 46 2002 1405 1406
47. C. Beyeler, M. Armstrong, H.A. Bird Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis Ann Rheum Dis. 55 1996 66 68
48. M.A. Brown, S. Edwards, E. Hoyle Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis Hum Mol Genet. 9 2000 1563 1566
49. A.E. Timms, A.M. Crane, A.M. Sims The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis Am J Hum Genet. 75 2004 587 595
50. F. McGarry, J. Neilly, N. Anderson A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis Rheumatology (Oxford). 40 2001 1359 1364
51. M. van der Paardt, J.B. Crusius, M.A. Garcia-Gonzalez Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis Rheumatology (Oxford). 41 2002 1419 1423
52. W.P. Maksymowych, J. Reeve, J.D. Reveille High throughput single nucleotide polymorphism (SNP) analysis of the interleukin-1 receptor antagonist (IL-1 RN) locus in patients with ankylosing spondylitis (AS) by MALDI-TOF mass spectroscopy Arthritis Rheum. 48 2003 2011 2018
53. L. Jin, G. Zhang, J.M. Akey Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility Arthritis Rheum. 50 2004 3047 3048
54. F.W. Tsui, H.W. Tsui, E.Y. Cheng Novel genetic markers in the 5'-flanking region of ANKH are associated with ankylosing spondylitis Arthritis Rheum. 48 2003 791 797
55. A.E. Timms, Y. Zhang, L. Bradbury Investigation of the role of ANKH in ankylosing spondylitis Arthritis Rheum. 48 2003 2898 2902
56. K. Mori, T. Ushiyama, K. Inoue, S. Hukuda Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis Rheumatology (Oxford). 39 2000 530 532
57. M.D. Collado-Escobar, A. Nieto, L. Mataran Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis J Rheumatol. 27 2000 1461 1463
58. V. Goedecke, A.M. Crane, E. Jaakkola Interleukin 10 polymorphisms in ankylosing spondylitis Genes Immun. 4 2003 74 76
59. H.S. Howe, P.L. Cheung, K.O. Kong Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis Rheumatology (Oxford). 44 2005 51 54
60. J. Balding, D. Kane, W. Livingstone Cytokine gene polymorphisms association with psoriatic arthritis susceptibility and severity Arthritis Rheum. 48 2003 1408 1413
61. M.A. Brown, S. Brophy, L. Bradbury Identification of major loci controlling clinical manifestations of ankylosing spondylitis Arthritis Rheum. 48 2003 2234 2239
62. M.A. Khan Update on spondyloarthropathies Ann Intern Med. 136 2002 896 907
63. S. Nikkari, K. Rantakokko, P. Ekman Salmonella-triggered reactive arthritis use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid Arthritis Rheum. 42 1999 84 89
64. H.C. Gerard, P.J. Branigan, H.R. Schumacher Jr, A.P. Hudson Synovial chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression J Rheumatol. 25 1998 734 742
65. H.R. Schumacher Jr, T. Arayssi, M. Crane Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects Arthritis Rheum. 42 1999 1281 1284
66. P. Cowling, R. Ebringer, A. Ebringer Association of inflammation with raised serum IgA in ankylosing spondylitis Ann Rheum Dis. 39 1980 545 549
67. M.A. Stone, U. Payne, C. Schentag Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis Rheumatology (Oxford). 43 2004 148 155
68. S. Stebbings, K. Munro, M.A. Simon Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis Rheumatology (Oxford). 41 2002 1395 1401
69. M. Cassandra, E. Conte, B. Cortez Childhood pustular psoriasis elicited by the streptococcal antigen a case report and review of the literature Pediatr Dermatol. 20 2003 506 510
70. H. Mielants, E.M. Veys, S. Goemaere Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology: a prospective study J Rheumatol. 18 1991 1542 1551
71. M. Leirisalo-Repo, U. Turunen, S. Stenman High frequency of silent inflammatory bowel disease in spondylarthropathy Arthritis Rheum. 37 1994 23 31
72. O. Martinez-Gonzalez, J. Cantero-Hinojosa, P. Paule-Sastre Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives Br J Rheumatol. 33 1994 644 647
73. D. van der Heijde, N. Bellamy, A. Calin Preliminary core sets for endpoints in ankylosing spondylitis assessments in Ankylosing Spondylitis Working Group J Rheumatol. 24 1997 2225 2229
74. S. Garrett, T.R. Jenkinson, L.G. Kennedy A new approach to defining disease status in ankylosing spondylitis. The Bath ankylosing spondylitis disease activity index J Rheumatol. 21 1994 2286 2291
75. A. Calin, S. Garrett, H.C. Whitelock A new approach to defining functional ability in ankylosing spondylitis. The Bath ankylosing spondylitis functional index J Rheumatol. 21 1994 2281 2285
76. L.H. Daltroy, M.G. Larson, N.W. Roberts, M.H. Liang A modification of the Health Assessment Questionnaire for the spondyloarthropathies J Rheumatol. 17 1990 946 950
77. T.R. Jenkinson, P.A. Mallorie, H.C. Whitelock Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index J Rheumatol. 21 1994 1694 1698
78. J.E. Ware Jr., C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care. 30 1992 473 483
79. K.L. Haywood, A.M. Garratt, K. Jordan Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis reliability, validity and responsiveness Rheumatology (Oxford). 41 2002 1295 1302
80. K. MacKay, C. Mack, S. Brophy, A. Calin The Bath ankylosing spondylitis radiology index (BASRI) a new validated approach to disease assessment Arthritis Rheum. 41 1998 665 669
81. A.J. Wanders, R.B. Landewe, A. Spoorenberg What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter Arthritis Rheum. 50 2004 2622 2632
82. J. Braun, X. Baraliakos, W. Golder Improvement of spinal inflammation in ankylosing spondylitis (AS) by infliximab therapy as assessed by magnetic resonance imaging (MRI) using a novel evaluated spinal scoring system Arthritis Rheum. 48 2003 1126 1136
83. Z. Uhrin, S. Kuzis, M.M. Ward Exercise and changes in health status in patients with ankylosing spondylitis Arch Intern Med. 160 2000 2969 2975
84. H. Dagfinrud, K. Hagen Physiotherapy interventions for ankylosing spondylitis Cochrane Database Syst Rev 2001 CD002822
85. M. Dougados, S. van der Linden, M. Leirisalo-Repo Sulfasalazine in the treatment of spondylarthropathy a randomized, multicenter, double-blind, placebo-controlled study Arthritis Rheum. 38 1995 618 627
86. D.O. Clegg, D.J. Reda, M. Abdellatif Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies a Department of Veterans Affairs cooperative study Arthritis Rheum. 42 1999 2325 2329
87. A. Taggart, P. Gardiner, F. McEnvoy Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized controlled study Arthritis Rheum. 39 1996 1400 1405
88. M.C. Creemers, M.J. Franssen, L.B. van de Putte Methotrexate in severe ankylosing spondylitis an open study J Rheumatol. 22 1995 1104 1107
89. L. Altan, U. Bingol, Y. Karakoc Clinical investigation of methotrexate in the treatment of ankylosing spondylitis Scand J Rheumatol. 30 2001 255 259
90. Y. Maugars, C. Mathis, J.M. Berthelot Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies a double-blind study Br J Rheumatol. 35 1996 767 770
91. A. Lauhio, M. Leirisalo-Repo, J. Lahdevirta Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis Arthritis Rheum. 34 1991 6 14
92. K. Laasila, L. Laasonen, M. Leirisalo-Repo Antibiotic treatment and long term prognosis of reactive arthritis Ann Rheum Dis. 62 2003 655 658
93. T. Yli-Kerttula, R. Luukkainen, U. Yli-Kerttula Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis Ann Rheum Dis. 62 2003 880 884
94. W.P. Maksymowych, R. Lambert, G.S. Jhangri Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy J Rheumatol. 28 2001 144 155
95. F. Huang, J. Gu, W. Zhao One-year open-label trial of thalidomide in ankylosing spondylitis Arthritis Rheum. 47 2002 249 254
96. J. Brandt, H. Haibel, D. Cornely Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab Arthritis Rheum. 43 2000 1346 1352
97. J. Braun, J. Brandt, J. Listing Two-year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis Ann Rheum Dis. 64 2005 229 234
98. L. De Rycke, E. Kruithof, N. Van Damme Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy Arthritis Rheum. 48 2003 1015 1023
99. J. Gorman, K.E. Sack, J.C. Davis Jr Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α N Engl J Med. 346 2002 1349 1356
100. J. Davis Jr, A. Webb, S. Lund, K. Sack Results from an open-label extension study of etanercept in ankylosing spondylitis Arthritis Rheum. 51 2004 302 304
101. H. Marzo-Ortega, D. McGonagle, P. O'Connor, P. Emery Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy a clinical and magnetic resonance imaging study Arthritis Rheum. 44 2001 2112 2117
102. P.J. Mease, B.S. Goffe, J. Metz Etanercept in the treatment of psoriatic arthritis and psoriasis a randomised trial Lancet. 356 2000 385 390
103. J.R. Smith, R.D. Levinson, G.N. Holland Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease Arthritis Rheum. 45 2001 252 257
104. J. Braun, T. Pham, J. Sieper International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis Ann Rheum Dis. 62 2003 817 824
105. B.M. Obermayer-Pietsch, U. Lange, G. Tauber Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis Osteoporos Int. 14 2003 995 1000
106. J.F. Maillefert, L.S. Aho, A. El Maghraoui Changes in bone density in patients with ankylosing spondylitis a two-year follow-up study Osteoporos Int. 12 2001 605 609
107. U. Lange, O. Jung, J. Teichmann, G. Neeck Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis Osteoporos Int. 12 2001 1031 1035
108. E. Demis, C. Roux, M. Breban, M. Dougados Infliximab in spondylarthropathy-influence on bone density Clin Exp Rheumatol. 20 6 Suppl 28 2002 S185 S186
109. S. Sweeney, R. Gupta, G. Taylor, A. Calin Total hip arthroplasty in ankylosing spondylitis outcome in 340 patients J Rheumatol. 28 2001 1862 1866
110. M.R. Brinker, A.G. Rosenberg, L. Kull, D.D. Cox Primary noncemented total hip arthroplasty in patients with ankylosing spondylitis clinical and radiographic results at an average follow-up period of 6 years J Arthroplasty. 11 1996 802 812
111. D. Mitra, D.M. Elvins, D.J. Speden, A.J. Collins The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density Rheumatology (Oxford). 39 2000 85 89
112. B.J. Van Royen, A. De Gast Lumbar osteotomy for correction of thoracolumbar kyphotic deformity in ankylosing spondylitis a structured review of three methods of treatment Ann Rheum Dis. 58 1999 399 406
113. M.M. Ward, S. Kuzis Ceiling effects and the Schober test J Rheumatol. 30 2003 2732 2733
114. G. Sahin, M. Calikoglu, C. Ozge Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis Clin Rheumatol. 23 2004 199 202
115. L. Heuft-Dorenbosch, D. Vosse, R. Landewe Measurement of spinal mobility in ankylosing spondylitis comparison of occiput-to-wall and tragus-to-wall distance J Rheumatol. 31 2004 1779 1784
116. A. Ezquerra, R. Bragado, M.A. Vega Primary structure of papain-solubilized human histocompatibility antigen HLA-B27 Biochemistry. 254 1985 1733 1741